PARTNER 2A
2016
Placement of Aortic Transcatheter Valves 2, Cohort A
In 2,032 intermediate-risk patients with severe aortic stenosis, transcatheter aortic-valve replacement was non-inferior for 2-year death or disabling stroke compared with surgical aortic-valve replacement.
Result
Efficacy: Death from any cause or disabling stroke at 2 yearsHR 0.89 (95% CI 0.73-1.09) · P = 0.001
Below 1 favours transcatheter aortic-valve replacement, above 1 favours surgical aortic-valve replacement.
- Absolute difference
- 1.8 points
The absolute difference is derived from the event rates.
Also reported: With a trend favouring TAVR in the transfemoral cohort.
- Subtopic
- TAVR
- Design
- Multicentre RCT, non-inferiority
- Relevance
- Supporting: context rather than must-know.
- Cited in
- ESC 2025 VHDACC/AHA 2020 VHD
- Source
- Leon MB, et al. N Engl J Med. 2016;374(17):1609-20.doi 10.1056/NEJMoa1514616
Discussion & critique
Used the now-superseded SAPIEN XT (more paravalvular leak and vascular complications) and included transthoracic access in some patients. Pivotal in extending TAVR from high-risk to intermediate-risk aortic stenosis.